Central Nervous System Stimulants
"Central Nervous System Stimulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
| Descriptor ID |
D000697
|
| MeSH Number(s) |
D27.505.696.282 D27.505.954.427.220
|
| Concept/Terms |
Analeptics- Analeptics
- Analeptic Drugs
- Drugs, Analeptic
- Analeptic Agents
- Agents, Analeptic
|
Below are MeSH descriptors whose meaning is more general than "Central Nervous System Stimulants".
Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Stimulants".
This graph shows the total number of publications written about "Central Nervous System Stimulants" by people in this website by year, and whether "Central Nervous System Stimulants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 2 | 0 | 2 |
| 2016 | 1 | 1 | 2 |
| 2017 | 9 | 11 | 20 |
| 2018 | 15 | 6 | 21 |
| 2019 | 4 | 2 | 6 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Central Nervous System Stimulants" by people in Profiles.
-
The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021 07 01; 34(4):344-350.
-
Insights in Public Health: Methamphetamine Use during COVID-19 in Hawai'i. Hawaii J Health Soc Welf. 2021 05; 80(5):117-118.
-
Patient access to chronic medications during the Covid-19 pandemic: Evidence from a comprehensive dataset of US insurance claims. PLoS One. 2021; 16(4):e0249453.
-
Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19. BMJ Case Rep. 2021 Mar 02; 14(3).
-
Why METH users are at high risk of fatality due to COVID-19 infection? Expert Rev Vaccines. 2020 12; 19(12):1101-1103.
-
Increase in drugs-of-abuse findings in post-mortem toxicology due to COVID-19 restrictions-First observations in Finland. Drug Test Anal. 2021 Apr; 13(4):867-870.
-
Adaptation of contingency management for stimulant use disorder during the COVID-19 pandemic. J Subst Abuse Treat. 2020 11; 118:108102.
-
ADHD as a Risk Factor for Infection With Covid-19. J Atten Disord. 2021 11; 25(13):1783-1790.
-
Ritonavir/Lopinavir and Its Potential Interactions With Psychiatric Medications: A COVID-19 Perspective. Prim Care Companion CNS Disord. 2020 06 18; 22(3).
-
Indole Tryptophan Metabolism and Cytokine S100B in Children with Attention-Deficit/Hyperactivity Disorder: Daily Fluctuations, Responses to Methylphenidate, and Interrelationship with Depressive Symptomatology. J Child Adolesc Psychopharmacol. 2020 04; 30(3):177-188.